182 related articles for article (PubMed ID: 31625162)
1. Haspin inhibition delays cell cycle progression through interphase in cancer cells.
Wang P; Hua X; Bryner YH; Liu S; Gitter CB; Dai J
J Cell Physiol; 2020 May; 235(5):4508-4519. PubMed ID: 31625162
[TBL] [Abstract][Full Text] [Related]
2. Loss of haspin suppresses cancer cell proliferation by interfering with cell cycle progression at multiple stages.
Wang P; Hua X; Sun Y; Li H; Bryner YH; Hsung RP; Dai J
FASEB J; 2021 Oct; 35(10):e21923. PubMed ID: 34551143
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the antiproliferative effects of the HASPIN inhibitor CHR-6494 in breast cancer cell lines.
Nishida-Fukuda H; Tokuhiro K; Ando Y; Matsushita H; Wada M; Tanaka H
PLoS One; 2021; 16(4):e0249912. PubMed ID: 33852630
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin.
Huertas D; Soler M; Moreto J; Villanueva A; Martinez A; Vidal A; Charlton M; Moffat D; Patel S; McDermott J; Owen J; Brotherton D; Krige D; Cuthill S; Esteller M
Oncogene; 2012 Mar; 31(11):1408-18. PubMed ID: 21804608
[TBL] [Abstract][Full Text] [Related]
5. Haspin-dependent and independent effects of the kinase inhibitor 5-Iodotubercidin on self-renewal and differentiation.
Karanika E; Soupsana K; Christogianni A; Stellas D; Klinakis A; Politou AS; Georgatos S
Sci Rep; 2020 Jan; 10(1):232. PubMed ID: 31937797
[TBL] [Abstract][Full Text] [Related]
6. Design of new disubstituted imidazo[1,2-
Elie J; Feizbakhsh O; Desban N; Josselin B; Baratte B; Bescond A; Duez J; Fant X; Bach S; Marie D; Place M; Ben Salah S; Chartier A; Berteina-Raboin S; Chaikuad A; Knapp S; Carles F; Bonnet P; Buron F; Routier S; Ruchaud S
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1840-1853. PubMed ID: 33040634
[TBL] [Abstract][Full Text] [Related]
7. Polo-like kinase-1 triggers histone phosphorylation by Haspin in mitosis.
Zhou L; Tian X; Zhu C; Wang F; Higgins JM
EMBO Rep; 2014 Mar; 15(3):273-81. PubMed ID: 24413556
[TBL] [Abstract][Full Text] [Related]
8. Exploring the thermodynamic, kinetic and inhibitory mechanisms of 5-iTU targeting mitotic kinase haspin by integrated molecular dynamics.
Wang Q; Zhang Q; Leung ELH; Chen Y; Yao X
Phys Chem Chem Phys; 2021 Sep; 23(34):18404-18413. PubMed ID: 34612381
[TBL] [Abstract][Full Text] [Related]
9. Chromosome segregation regulation in human zygotes: altered mitotic histone phosphorylation dynamics underlying centromeric targeting of the chromosomal passenger complex.
van de Werken C; Avo Santos M; Laven JS; Eleveld C; Fauser BC; Lens SM; Baart EB
Hum Reprod; 2015 Oct; 30(10):2275-91. PubMed ID: 26223676
[TBL] [Abstract][Full Text] [Related]
10. Function and inhibition of Haspin kinase: targeting multiple cancer therapies by antimitosis.
Liu Y; Yang H; Fang Y; Xing Y; Pang X; Li Y; Zhang Y; Liu Y
J Pharm Pharmacol; 2023 Apr; 75(4):445-465. PubMed ID: 36334086
[TBL] [Abstract][Full Text] [Related]
11. Autoinhibition and Polo-dependent multisite phosphorylation restrict activity of the histone H3 kinase Haspin to mitosis.
Ghenoiu C; Wheelock MS; Funabiki H
Mol Cell; 2013 Dec; 52(5):734-45. PubMed ID: 24184212
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the chromatin phosphoproteome by the Haspin protein kinase.
Maiolica A; de Medina-Redondo M; Schoof EM; Chaikuad A; Villa F; Gatti M; Jeganathan S; Lou HJ; Novy K; Hauri S; Toprak UH; Herzog F; Meraldi P; Penengo L; Turk BE; Knapp S; Linding R; Aebersold R
Mol Cell Proteomics; 2014 Jul; 13(7):1724-40. PubMed ID: 24732914
[TBL] [Abstract][Full Text] [Related]
13. The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation and normal metaphase chromosome alignment.
Dai J; Sultan S; Taylor SS; Higgins JM
Genes Dev; 2005 Feb; 19(4):472-88. PubMed ID: 15681610
[TBL] [Abstract][Full Text] [Related]
14. Structure, Roles and Inhibitors of a Mitotic Protein Kinase Haspin.
Kestav K; Uri A; Lavogina D
Curr Med Chem; 2017; 24(21):2276-2293. PubMed ID: 28413956
[TBL] [Abstract][Full Text] [Related]
15. Slowly on, Slowly off: Bisubstrate-Analogue Conjugates of 5-Iodotubercidin and Histone H3 Peptide Targeting Protein Kinase Haspin.
Kestav K; Viht K; Konovalov A; Enkvist E; Uri A; Lavogina D
Chembiochem; 2017 Apr; 18(8):790-798. PubMed ID: 28181383
[TBL] [Abstract][Full Text] [Related]
16. HASPIN kinase inhibitor CHR-6494 suppresses intestinal polyp development, cachexia, and hypogonadism in Apcmin/+ mice.
Tanaka H; Wada M; Park J
Eur J Cancer Prev; 2020 Nov; 29(6):481-485. PubMed ID: 31833958
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mixed-lineage kinase (MLK) activity during G2-phase disrupts microtubule formation and mitotic progression in HeLa cells.
Cha H; Dangi S; Machamer CE; Shapiro P
Cell Signal; 2006 Jan; 18(1):93-104. PubMed ID: 15923109
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of H3-Thr3 by Haspin Is Required for Primary Cilia Regulation.
Quadri R; Sertic S; Ghilardi A; Rondelli D; Gallo GR; Del Giacco L; Muzi-Falconi M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299370
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles of haspin in stem cell division and male gametogenesis.
Soupsana K; Karanika E; Kiosse F; Christogianni A; Sfikas Y; Topalis P; Batistatou A; Kanaki Z; Klinakis A; Politou AS; Georgatos S
Sci Rep; 2021 Oct; 11(1):19901. PubMed ID: 34615946
[TBL] [Abstract][Full Text] [Related]
20. The N-Terminal Non-Kinase-Domain-Mediated Binding of Haspin to Pds5B Protects Centromeric Cohesion in Mitosis.
Zhou L; Liang C; Chen Q; Zhang Z; Zhang B; Yan H; Qi F; Zhang M; Yi Q; Guan Y; Xiang X; Zhang X; Ye S; Wang F
Curr Biol; 2017 Apr; 27(7):992-1004. PubMed ID: 28343965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
